- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Robert Galvin, MD, Speaks About the Patient-Centered Medical Home Model
Robert Galvin, MD, CEO, Equity Healthcare, The BlackStone Group, says that as a primary care physician he has a bias that the patient-centered medical home is a great model, but it is very difficult to implement.
Robert Galvin, MD, CEO, Equity Healthcare, The BlackStone Group, says that as a primary care physician he has a bias that the patient-centered medical home (PCMH) is a great model, but it is very difficult to implement. There are many challenges to ensure the success and longevity of a PCMH. For example, the lack of time for physicians to spend with patients, a large enough staff, and expensive IT systems are all issues that the PCMH faces.
Dr Galvin says that more capital, more investments, and patience are all necessary for the model to mature.
Impact of Amivantamab-Lazertinib on EGFR, MET Resistance Alterations in NSCLC: Danny Nguyen, MD
September 15th 2025The combination of amivantamab and lazertinib in first-line non–small cell lung cancer (NSCLC) significantly reduces resistance mechanisms with implications for second-line treatment, said Danny Nguyen, MD, of City of Hope.
Read More
Disparities in Biomarker Testing Impact Nonsquamous NSCLC Outcomes: Surbhi Singhal, MD
September 6th 2025Surbhi Singhal, MD, of the University of California Davis, discussed disparities in biomarker testing among patients diagnosed with stage IV nonsquamous non–small cell lung cancer (NSCLC).
Read More
